SPAC D&O Insurance
SPAC D&O insurance requires planning around a corporate lifecycle that looks very different from a traditional operating company. A special purpose acquisition company begins as a public shell, raises capital through an IPO, searches for a private operating company, negotiates and discloses a proposed business combination, and ultimately completes a de-SPAC transaction or liquidates.
Each stage can create distinct exposures for the SPAC, its directors and officers, and other insured persons. Churchwell Insurance Agency works within the SPAC and public-company ecosystem to help sponsors and leadership teams evaluate D&O structure, policy wording, limits, extensions, runoff, and the transition into the post-combination public company.
The SPAC D&O lifecycle.
- Formation and IPO
The D&O program should be designed around the SPAC’s structure, proposed offering, sponsor relationship, leadership team, target criteria, jurisdiction, and expected lifecycle. The policy should clearly identify the insured organization and insured persons and should be reviewed for exclusions or endorsements that could affect a future business combination. - Target Search
During the search period, the SPAC’s directors and officers make decisions about potential targets, diligence, valuation, financing, extensions, disclosure, and conflicts. Insurance planning should keep pace with material changes in the SPAC’s timeline and transaction posture. - Proposed Business Combination
Once a transaction is announced, the exposure can expand. Public disclosures, projections, sponsor economics, board process, fairness considerations, financing, redemptions, and statements about the target may all receive scrutiny from shareholders, regulators, plaintiffs’ firms, and the market. - De-SPAC Closing
At closing, the SPAC’s historical D&O exposure generally needs to transition into runoff while the combined operating company places a new public-company D&O program. The dates, definitions, policy triggers, and change-in-control language must be coordinated carefully so the parties understand which policy is intended to respond to pre-closing and post-closing wrongful acts. - Liquidation
If the SPAC does not complete a business combination, directors and officers may still face claims arising from the SPAC’s public life, disclosures, trust arrangements, extensions, liquidation process, or other alleged wrongful acts. Tail and reporting provisions remain important even when no de-SPAC occurs.
SPAC D&O issues that deserve specific review.
- Who qualifies as an insured person
- Whether and how sponsor-related entities or sponsor personnel are protected
- Securities claim definitions
- Public offering or transaction exclusions
- Conduct exclusions and severability
- Insured-versus-insured language
- Investigation coverage
- Extensions and policy period mechanics
- Prior acts and prior notice provisions
- Change-in-control trigger
- Runoff duration and terms
- Reporting requirements and extended reporting periods
- Excess tower follow-form language
- Allocation of defense and settlement costs
The regulatory environment changed.
The SEC adopted rules in 2024 that enhanced disclosure requirements for SPAC IPOs and de-SPAC transactions, including disclosures concerning sponsor compensation, conflicts of interest, dilution, target-company information, and projections. The rules also more closely align certain de-SPAC disclosure and liability concepts with traditional IPOs. That regulatory framework reinforces why D&O planning should be treated as part of the transaction workstream, not as an administrative purchase made in isolation.
Coverage disputes can surface years later.
The long tail of SPAC risk is not theoretical. Courts continue to address D&O coverage disputes arising from earlier de-SPAC transactions. In 2026, The D&O Diary reported on a Delaware Superior Court decision involving View Operating Corporation in which a public-offering exclusion was litigated in connection with de-SPAC-related claims. The lesson is straightforward: transaction-specific policy language can matter long after the original SPAC IPO or business combination.
Churchwell in the SPAC ecosystem.
Churchwell does more than observe the SPAC market from outside it. Chaz Churchwell has appeared on The SPAC Podcast to discuss sponsor D&O coverage, policy customization, pricing, and the transition from SPAC to de-SPAC. Churchwell also produces The DESPAC Podcast, where Chaz speaks with attorneys, investment bankers, accounting professionals, transfer agents, executives, and other practitioners involved in taking companies public through SPAC transactions.
Planning a SPAC IPO, approaching an extension, evaluating a proposed business combination, or preparing for runoff? Contact Churchwell’s Executive Liability Team to review the D&O structure before the next transaction milestone.
A SPAC should address D&O before it becomes publicly exposed to claims. The program should be designed around the SPAC’s lifecycle, including the IPO, target-search period, proposed business combination, closing or liquidation. Waiting until a target is identified can leave important questions about prior acts, sponsor exposure, reporting periods and runoff unresolved.
A SPAC D&O policy is generally designed to protect insured directors and officers and, for defined claims, the SPAC entity. Whether the sponsor, sponsor personnel or other affiliated parties are insured depends on the definitions and endorsements in the actual policy. Sponsor protection should never be assumed from the name of the policy alone.
No. Sponsor coverage is a policy-specific issue. A sponsor may be a separate legal entity and can have interests or activities that do not fall automatically within the SPAC’s insured-person or insured-entity definitions. The broker, carrier and coverage counsel should review sponsor structure, sponsor personnel and the capacities in which individuals are acting.
The pre-closing SPAC generally needs runoff, sometimes called tail coverage, for claims arising from wrongful acts that allegedly occurred before the business combination. The newly public operating company typically needs its own go-forward public-company D&O program. The transaction creates an important dividing line, so the runoff and new policy should be coordinated to avoid unintended gaps.
Runoff duration is a risk-management decision that should consider applicable statutes of limitation, the transaction structure, policy terms, contractual requirements and the potential for claims to emerge after closing. Six-year runoff periods are common in many M&A and D&O contexts, but the appropriate period should be evaluated for the specific SPAC and transaction rather than treated as automatic.
A SPAC extension can affect the insurance program because the original policy period may not match the extended target-search timeline. Before an extension is completed, the SPAC should confirm policy expiration, available extensions, pricing, changes in underwriting information and how any renewal or extension affects continuity and prior acts.
SPAC-related claims can involve disclosures, projections, conflicts of interest, sponsor economics, dilution, board process, target diligence, redemption mechanics, financing, alleged fiduciary-duty breaches, securities-law allegations and post-closing performance. The SEC’s current SPAC framework also requires enhanced disclosures in several of these areas, increasing the importance of disciplined governance and clear transaction documentation
Limit selection should consider IPO size, trust size, sponsor structure, board composition, industry focus, target-search period, transaction size, financing plans, claims trends, peer purchasing and the expected cost of runoff. Dedicated Side A protection should be evaluated separately because protecting individual directors and officers is not the same question as protecting the SPAC’s balance sheet.
Let’s Get Started
SPAC D&O Insurance Quote Request
"*" indicates required fields
Don’t like forms? Contact us at or email us.
